Skip to content

Efficacy and Safety of High Dose Intravenous Iron for Correcting Anemia and Reducing Blood Transfusion in Patient Undergoing Hysterectomy: Retrospective Cohort Study

Efficacy and Safety of High Dose Intravenous Iron for Correcting Pre-operative Anemia in Patient Undergoing Hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240422011
Enrollment
124
Registered
2024-04-22
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing hysterectomy who have iron deficiency anemia iron deficiency anemia, hysterectomy, patients undergoing hysterectomy

Interventions

recieved High dose IV Iron, Ferric carboxymaltose ,received oral Iron supplement, Ferrous fumarate
Treatment,Treatment
High dose IV Iron,Oral Iron supplement

Sponsors

Faculty of Medicine Khon Kaen University Research Fund
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with uterine tumor and/or abnormal vaginal bleeding such as Leiomyoma, Adenomyosis, Endometrial hyperplasia, heavy menstrual bleeding, etc. 2. Patients who had hysterectomy at Srinakarind Hospital during 1 January 2020 to 31 August 2023. 3. Patients older than or equal to 20 years old. 4. Patients with blood concentration values less than 12 (Hb < 12 g/dL)

Exclusion criteria

Exclusion criteria: 1.Patients who have been diagnosed with cancer 2.Patients who have undergone surgery and lost more than 1,000 ml of blood 3.Patients with chronic diseases such as thalassemia anemia, blood-dependent type 4.Patients with anemia due to abnormal bone marrow function 5.Patients who receive chemotherapy 6.Patients with Ferritin > 800 ng/mL 7.Patients with transferrin saturation (TSAT) more than and equal 50% 8.Patients with incomplete or missing records and medical history

Design outcomes

Primary

MeasureTime frame
Hemoconcentration change pre-operative Hb, Hit

Secondary

MeasureTime frame
Blood transfusion rate Pre-operative, intra-operative, post-operative number of blood transfusion

Countries

Thailand

Contacts

Public ContactKamonphan Pinjaroen

Faculty of Medicine,Khon Kaen University

Kamonpi@kku.ac.th0933208907

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026